Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383456 · ClinicalTrials.gov registry record
The Visceral Adiposity Measurement and Observation Study
A clinical trial, sponsored by Theratechnologies.
- Completed
- Registry status
- 196
- Enrollment target
NCT05383456: Completed study, sponsored by Theratechnologies.
NCT05383456 is a clinical trial that has completed, run by Theratechnologies. The registered enrollment target is 196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05383456 has completed, sponsored by Theratechnologies.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
The Visceral Adiposity Measurement and Observation Study
Primary Outcome
Two types of waist circumference (WC) measurements (umbilical and iliac) will be assessed for a predicting relationship to Excess Visceral Adiposity (EVA) as measured by CT surface area.
Interventions
- DIAGNOSTIC_TEST Diagnostic Test
- DRUG HIV Anti-retroviral Background Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2023-10-30 |
What the finished NCT05383456 record still lists
NCT05383456 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Diagnostic Test is the first listed.
NCT05383456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05383456 about?
NCT05383456 is a clinical study titled "The Visceral Adiposity Measurement and Observation Study". The Visceral Adiposity Measurement and Observation Study
What is the current status of trial NCT05383456?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2022-04-18. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT05383456?
The interventions under investigation include: Diagnostic Test (DIAGNOSTIC_TEST), HIV Anti-retroviral Background Therapy (DRUG).
Who is sponsoring clinical trial NCT05383456?
This trial is sponsored by Theratechnologies, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI